GBI 0.00% 16.0¢ genera biosystems limited

Ann: Results of Major Clinical Study-Genera Biosy, page-10

  1. 50 Posts.
    re: Ann: Results of Major Clinical Study-Gene... Prof,

    If the results appear a bit anomalous then you would have to say GBI’s claim that their test is superior to HC-2 is a bit premature.
    On face value I don’t think you can conclude anything.
    It’s like the three blind men and the elephant; none has enough information to tell you correctly what the elephant looks like.

    These guys need to publish some papers
 
watchlist Created with Sketch. Add GBI (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.